Adaptimmune Therapeutics PLC

Ownership Transactions Reported by 21 Insiders

Symbol
ADAP on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
60 Jubilee Avenue, Milton Park, Abingdon, Oxfordshire, United Kingdom

Insiders trading volume in the past year

Adaptimmune Therapeutics PLC executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
E. Garry Menzel Director $50.5K Jul 1, 2024
Cintia Piccina Chief Commercial Officer $35.6K -$22.8K -39% Jun 18, 2024
Adrian Rawcliffe Chief Executive Officer, Director $30.2K -$52.3K -63.4% Jan 16, 2024
William Bertrand Chief Operating Officer $13.6K -$24.2K -64.1% Jan 16, 2024
Elliot Norry Chief Medical Officer $13K -$24.1K -65.1% Jan 16, 2024
John Lunger Chief Patient Supply Officer $12.8K -$23.7K -64.9% Jan 16, 2024
Tal Zvi Zaks Director Jul 1, 2022
Joanna Brewer Chief Scientific Officer Jan 15, 2024
Priti Hegde Director Jul 1, 2024
Andrew Allen Director Jul 1, 2024
Gavin Wood Chief Financial Officer Jan 15, 2024
Barbara Gayle Duncan Director Jul 1, 2022
Charles Elliott Sigal Director Jul 3, 2023
David Mott Director Jul 1, 2024
EcoR1 Capital, LLC 10%+ Owner Mar 8, 2024
Lawrence M. Alleva Director Jul 1, 2024
Ali Behbahani Director Jul 1, 2024
Kristen Hege Director Jul 1, 2024
James Noble Director Jul 1, 2022
Helen Tayton Martin Chief Business & Strgy Officer Jan 15, 2024
John Furey Director Jul 1, 2024

Recent Insider Transactions by Companies or Individuals for Adaptimmune Therapeutics PLC

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.